Insider trade

Beone Medicines (ONC): Director sold ~$115K

Xiaodong Wang, Director at Beone Medicines, sold ~$115K of Beone Medicines shares.

~$115K
Approx. value · 320 sh @ $360.64
24K
Holds after · shares reported
Traded
Oct 27, 2026
Filed
Oct 29, 2026

What stands out in this filing

  • The sale was 1.3% of the shares this insider held before it; the filing reports 24,188 shares afterwards.
  • 320 shares at an average of $360.64 each, as reported on the form.
  • Footnote references a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 28, 2026Insider · 1 personInsiders: 10 sales (~$11.3M)
  2. Sep 30, 2026InsiderOfficer sold ~$418K of ONC shares in the open market
  3. Oct 13, 2026Insider · 1 personInsiders: 5 sales (~$10.9M)
  4. Oct 27, 2026 · this disclosureInsiderDirector sold ~$115K of ONC shares in the open market

What came next

  1. Oct 27, 2026Insider · 1 personInsiders: 10 sales (~$11.1M)
  2. Nov 5, 2026Company filing · Form 8-K · ResultsReported its results
  3. Nov 5, 2026Insider · 1 personInsiders: 2 sales (~$447K)
  4. Nov 6, 2026Insider · 1 personInsiders: 2 sales (~$632K)
  5. Nov 13, 20265% stakeOYLER JOHN reported a passive stake (13G) of 3.6%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Beone Medicines

For Beone Medicines, OQRO holds 34 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ONC page.

Other recent filings by Xiaodong Wang, Director

The full history of Xiaodong Wang, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Beone Medicines (ONC) insider traded, and how much?

Xiaodong Wang, Director at Beone Medicines, sold ~$115K of Beone Medicines shares. 320 shares at $360.64.

When did it happen, and when was it made public?

Traded: Oct 27, 2026. Filed: Oct 29, 2026. That is 2 days between the two dates.

What stands out in this filing?

The sale was 1.3% of the shares this insider held before it; the filing reports 24,188 shares afterwards. 320 shares at an average of $360.64 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Beone Medicines recently?

For Beone Medicines, OQRO holds 34 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the ONC page.

Does this mean ONC stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Beone Medicines

Everything OQRO holds on this company is on its ONC page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data